Standard Dosage Range
Research dosing range: 5–10% concentration
Educational reference only
Dosage by Use Case
General Anti-Wrinkle Serum
Ongoing
Apply to entire face, focusing on wrinkle-prone areas (forehead, crow’s feet). Use consistently for at least 4 weeks to assess efficacy. Combine with hyaluronic acid for hydration.
Targeted Expression Line Treatment
8–12 weeks
Apply directly to deep forehead furrows or glabellar lines. Press product into wrinkle creases rather than spreading. Combine with Matrixyl for collagen stimulation.
Eye Cream Formulation
Ongoing
Apply gently around the periorbital area (avoiding direct contact with eyes). Use as part of a comprehensive eye care routine.
Post-Procedure Maintenance (Botox/Fillers)
Ongoing
Use to prolong the effects of injectable neuromodulators. Apply nightly to treated areas. Consult with dermatologist for optimal integration.
Timing & Frequency
Apply to clean, dry skin before heavier products (moisturizer, sunscreen). Allow 2–3 minutes for absorption before applying the next layer of skincare. Morning and evening application is common.
Cycle Guidance
Argireline can be used continuously as part of a daily skincare routine. There is no need for cycling. Effects are maintained with consistent use and diminish upon discontinuation.
Reconstitution Reference
Quick reference for reconstituting Argireline. For custom vial sizes and concentrations, use the Reconstitution Calculator.
| Common Vial Size | N/A (typically supplied as a pre-mixed solution) |
| BAC Water Volume | N/A |
| Concentration & Draw | Typically 5–10% solution |
| Storage | Store at room temperature, away from direct sunlight. Follow manufacturer’s instructions. |
| Stability | Stable for 12–24 months per manufacturer specifications. |
Frequently Asked Questions
What is the standard Argireline dosage for wrinkle reduction?
How long does Argireline take to work?
Can I mix Argireline with other skincare ingredients?
Is it safe to use Argireline around the eyes?
What happens if I stop using Argireline?
References
- 1The cosmeceutical peptide Argireline decreases the expression of SNAP-25 and reduces the release of neurotransmitters: in vitro and in vivo studies(2002)PubMed ↗
- 2Anti-wrinkle efficacy of Argireline: in vitro analysis and clinical evaluation in a double-blind, placebo-controlled study(2009)PubMed ↗
- 3Acetyl hexapeptide-8 inhibits contraction of human facial skin: A randomized, double-blind, placebo-controlled study.(2023)PubMed ↗
Last updated: 2026-02-19